Skip to content

Treatment started early in HIV infection effective and well tolerated for up to five years

Genotypic resistance testing on a failing regimen is possible below 1000 copies/ml

Five cancers seen in vicriviroc study `not causally related`, study continues

New directions in HIV prevention: serosorting and universal testing

New directions in HIV prevention: circumcision and PREP

Best results in HIV-positive children if treatment started before five months of age

Merck announces 20% cut in efavirenz price for low and middle-income countries

Ukraine: anti-AIDS efforts undermined by human rights abuses

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS